Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

617
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
617
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

484
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
484
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

555
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
555
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

855
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
855
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

1.2K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.2K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential transcatheter closure of sinus venosus and secundum atrial septal defects using covered stents and a septal occluder, a two-step strategy: a case report.

Journal of medical case reports·2026
Same author

Role of primary protectors of plant cells in salinity tolerance: molecular mechanisms and adaptive strategies.

Plant signaling & behavior·2026
Same author

Magnesium-mediated stress adaptation in plants: from physio-biochemical insights to climate-resilient agriculture.

Frontiers in plant science·2026
Same author

Deep learning for estimating right ventricular function from routine coronary angiography.

European heart journal. Digital health·2026
Same author

Understanding the Pressure-Volume Loop in Valvular Heart Disease.

Heart, lung & circulation·2025
Same author

The Evolution of TEER From Good Enough to Getting It Right!

Heart, lung & circulation·2025

Related Experiment Video

Updated: Apr 15, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K

Percutaneous intervention for mitral regurgitation.

Mohammad Sarraf1, Ted Feldman1

  • 1NorthShore University HealthSystem, Evanston, IL, USA.

Heart Failure Clinics
|April 4, 2015
PubMed
Summary
This summary is machine-generated.

Percutaneous mitral regurgitation (MR) treatments offer hope for patients with functional MR (FMR) unsuitable for surgery. Transcatheter mitral valve replacement is a developing option needing more research for heart failure management.

Keywords:
Heart failureMitral regurgitationMitral valveValve replacement

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.8K
An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

7.7K

Related Experiment Videos

Last Updated: Apr 15, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.8K
An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

7.7K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Heart Failure Management

Background:

  • Functional mitral regurgitation (FMR) presents a treatment challenge, especially in patients ineligible for surgery.
  • Optimal management strategies for FMR remain undefined, unlike degenerative MR where repair is preferred.

Purpose of the Study:

  • To explore percutaneous treatment options for mitral regurgitation (MR), focusing on functional MR (FMR).
  • To address the challenges in developing novel mitral repair devices for high-risk patients.

Main Methods:

  • Review of current percutaneous treatment approaches for MR.
  • Discussion of emerging transcatheter mitral valve replacement (TMVR) technologies.

Main Results:

  • Percutaneous MR treatment is a viable alternative for specific patient groups.
  • Transcatheter mitral valve replacement shows feasibility but requires further clinical validation.

Conclusions:

  • Percutaneous interventions are promising for FMR patients not responding to standard therapies.
  • More clinical trials are essential to establish the role of TMVR in heart failure due to MR.